XM tidak menyediakan perkhidmatan kepada penduduk Amerika Syarikat.
B
B

Biomerieux


Berita

Barclays Bank, Ferrari, Volkswagen

EUROPE RESEARCH ROUNDUP-Barclays Bank, Ferrari, Volkswagen Sept 9 (Reuters) - Securities analysts revised their ratings and price targets on several European companies, including Barclays Bank, Ferrari and Volkswagen on Monday. HIGHLIGHTS * Barclays Bank BARC.L : Morgan Stanley raises target price to 300p from 290p * Ferrari RACE.MI : Citigroup raises target price to EUR 360 from EUR 334 * Mercedes-Benz Group AG MBGn.DE : Citigroup cuts target price to EUR 60 from EUR 65 * Shell Plc SHEL.L : HSB
A
A
A
B
B
B
B
B
B
B
C
E
E
F
F
F
H
H
H
K
L
P
R
R
R
R
T
U
V
V
A
D
I
I

Sales beat, outlook hike lift Biomerieux shares

BUZZ-Sales beat, outlook hike lift Biomerieux shares ** Shares in Biomerieux BIOX.PA rise 3.4% as the French biotechnology company publishes better-than-expected H1 results, ups guidance ** The group reports sales of 1.9 billion euros for the first half of 2024, a 8.2% beat when compared to a consensus cited by a Midcap analyst ** "The achievement
B

Biomerieux FY Sales Expected To Grow Organically By 8% to 10%

BRIEF-Biomerieux FY Sales Expected To Grow Organically By 8% to 10% Sept 5 (Reuters) - Biomerieux SA BIOX.PA : H1 OPERATING INCOME EUR 288 MILLION VERSUS EUR 208 MILLION H1 NET INCOME GROUP SHARE EUR 215 MILLION VERSUS EUR 162 MILLION H1 ORGANIC SALES EUR 1.90 BILLION 2024 FULL YEAR GUIDANCE REVISED UPWARD 2024 FULL YEAR GUIDANCE: SALES EXPECTED TO
B

Europe's STOXX 600 corporate earnings week ahead

DIARY-Europe's STOXX 600 corporate earnings week ahead Aug 30 (Reuters) - Diary of Europe's STOXX 600 (.STOXX) corporate earnings for the week ahead EUROPE'S STOXX 600 EARNINGS Start Date Start Time (GMT) RIC Company Name Event Name 02-Sep-2024 09:00 BAYGn.DE Bayer AG Bayer AG Investor Webinar to Discuss Results from FINEARTS-HFP 02-Sep-2024 09:00 PZU.WA Powszechny Zaklad Ubezpieczen SA Half Year 2024 Powszechny Zaklad Ubezpieczen SA Investor Chat (Polish) 03-Sep-2024 NTS BKWB.S BKW AG Half Year
A
B
B
B
H
R
S
D
S

Top of the Street: Admiral Group, United Utilities, Biomerieux

BUZZ-Top of the Street: Admiral Group, United Utilities, Biomerieux A round-up of notable broker activity this morning from Europe's top-ranked* analysts: ** Jefferies raises Admiral Group ADML.L to "hold" from "underperform" after the British financial services company exceeded expectations for growth and margin in the first half ** UBS upgrades United Utilities UU.L to "buy" from "neutral" saying the UK water company is trading close to post-2010 multiple lows, while the financial framework th
A
B
U

European stocks rise on rate cut hopes, healthcare sector hits record high

UPDATE 2-European stocks rise on rate cut hopes, healthcare sector hits record high For a Reuters live blog on U.S., UK and European stock markets, click LIVE/ or type LIVE/ in a news window Euro zone business activity gets boost from Olympics- PMI ECB policymakers shift focus to September meeting UK's JD Sports gains on Q2 sales rise GN hits bottom of STOXX as earnings miss expectations DB rises after settlement with some plaintiffs STOXX 600 up 0.4% Updated at 1600 GMT By Ankika Biswas and Pra
A
B
J
S
U
E
F
U
G

UBS sees Biomerieux as compelling entry point, starts with 'buy'

BUZZ-UBS sees Biomerieux as compelling entry point, starts with 'buy' ** UBS initiates coverage of French biotechnology company Biomerieux BIOX.PA with "buy", calling it a compelling entry point ** The broker points to the company's new point-of-care technology SPOTFIRE as so game changing compared to existing technologies that it can expand the ma
B

Admiral, Capgemini, Zurich Insurance Group

EUROPE RESEARCH ROUNDUP- Admiral, Capgemini, Zurich Insurance Group Aug 22 (Reuters) - Securities analysts revised their ratings and price targets on several European companies, including Admiral, Capgemini and Zurich Insurance Group, on Thursday. HIGHLIGHTS * Admiral ADML.L : Jefferies raises to hold from underperform * Capgemini CAPP.PA : Jefferies cuts target price to EUR 185 from EUR 195 * Glenveagh Properties Plc GLV.I : Jefferies raises to buy from hold * Orsted ORSTED.CO : Deutsche Bank c
A
A
A
B
B
C
D
D
E
E
H
H
O
P
R
S
S
S
S
T
T
T
V
I
U
Z

Ascential Plc, Oxford Instruments, Reckitt Benckiser

EUROPE RESEARCH ROUNDUP-Ascential Plc, Oxford Instruments, Reckitt Benckiser July 25 (Reuters) - Securities analysts revised their ratings and price targets on several European companies, including Ascential Plc, Oxford Instruments and Reckitt Benckiser, on Thursday. HIGHLIGHTS * Ascential Plc ASCL.L : HSBC raises target price to 568p from 370p * Oxford Instruments OXIG.L : HSBC raises target price to 2850p from 2500p * Reckitt Benckiser RKT.L : HSBC cuts target price to 4800p from 4900p * RS Gr
A
A
A
B
B
C
D
D
E
E
K
K
O
R
S
S
U
A
A
A
B
E

Biomerieux Gets FDA Special 510(K) Clearance For Biofire Spotfire Respiratory/Sore Throat Panel Mini

BRIEF-Biomerieux Gets FDA Special 510(K) Clearance For Biofire Spotfire Respiratory/Sore Throat Panel Mini June 26 (Reuters) - Biomerieux SA BIOX.PA : RECEIVES U.S. FDA SPECIAL 510(K) CLEARANCE AND CLIA-WAIVER FOR ITS BIOFIRE® SPOTFIRE® RESPIRATORY/SORE THROAT (R/ST) PANEL MINI THE NEW BIOFIRE SPOTFIRE R/ST PANEL MINI WILL BE AVAILABLE IN THE THI
B



Syarat

Aset Popular

Penafian: Entiti XM Group menyediakan perkhidmatan pelaksanaan sahaja dan akses ke Kemudahan Dagangan Atas Talian, yang membolehkan sesorang melihat dan/atau menggunakan kandungan yang ada di dalam atau melalui laman web, tidak bertujuan untuk mengubah atau memperluas, juga tidak mengubah atau mengembangkannya. Akses dan penggunaan tersebut tertakluk kepada: (i) Terma dan Syarat; (ii) Amaran Risiko; dan Penafian Penuh. Oleh itu, kandungan sedemikian disediakan tidak lebih dari sekadar maklumat umum. Terutamanya, perlu diketahui bahawa kandungan Kemudahan Dagangan Atas Talian bukan permintaan, atau tawaran untuk melakukan transaksi dalam pasaran kewangan. Berdagang dalam mana-mana pasaran kewangan melibatkan tahap risiko yang besar terhadap modal anda.

Semua bahan yang diterbitkan di Kemudahan Dagangan Atas Talian kami bertujuan hanya untuk tujuan pendidikan/maklumat dan tidak mengandungi – dan tidak boleh dianggap mengandungi nasihat kewangan, cukai pelaburan atau dagangan dan cadangan, atau rekod harga dagangan kami, atau tawaran, atau permintaan untuk suatu transaksi dalam sebarang instrumen kewangan atau promosi kewangan yang tidak diminta kepada anda.

Sebarang kandungan pihak ketiga serta kandungan yang disediakan oleh XM, seperti pendapat, berita, penyelidikan, analisis, harga, maklumat lain atau pautan ke laman web pihak ketiga yang terdapat dalam laman web ini disediakan berdasarkan "seadanya" sebagai ulasan pasaran umum dan bukanlah nasihat pelaburan. Sesuai dengan apa-apa kandungan yang ditafsir sebagai penyelidikan pelaburan, anda mestilah ambil perhatian dan menerima bahawa kandungan tersebut tidak bertujuan dan tidak sediakan berdasarkan keperluan undang-undang yang direka untuk mempromosikan penyelidikan pelaburan bebas dan oleh itu, ia dianggap sebagai komunikasi pemasaran di bawah peraturan dan undang-undang yang berkaitan. SIla pastikan bahawa anda telah membaca dan memahami Notifikasi mengenai Penyelidikan Pelaburan Bukan Bebas dan Amaran Risiko mengenai maklumat di atas yang boleh diakses di sini.

Amaran Risiko: Modal anda dalam risiko. Produk yang berleveraj mungkin tidak sesuai untuk semua individu. Sila pertimbangkan Pendedahan Risiko kami.